Science AI Journal

Seminars in Liver Disease

ISSN 0272-8087 · Thieme Medical Publishers (Germany) · United States · active 1970–2026

Metrics

Scimago quartile
Q1
Cites per paper (2y)
6.2
SJR
1.45
h-index
169

“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.

Indexing & access

ScopusWeb of SciencePubMed

Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.

Scope

liverdiseasediagnosistreatmentepidemiologytransplantationhepatologyhepatitisvirusdiseasesimmunityorgan

Frequently asked

Is Seminars in Liver Disease a predatory journal?

Our screening does not flag Seminars in Liver Disease. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.

Is Seminars in Liver Disease indexed in Scopus or Web of Science?

Per our venue index, Seminars in Liver Disease appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.

What is Seminars in Liver Disease's impact?

Papers in Seminars in Liver Disease are cited about 6.2 times each within two years of publication, and Scimago places it in Q1, with an h-index of 169. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.

Is Seminars in Liver Disease open access?

We hold no reliable open-access classification for Seminars in Liver Disease. Check the journal's own site for its access model and any article processing charge.

Similar venues

Command palette

Jump anywhere, run any action.